Drug Type Small molecule drug |
Synonyms Drixoral Plus |
Mechanism ADRA1 agonists(Adrenergic receptor alpha-1 agonists), ADRA2 agonists(Adrenergic receptors alpha-2 agonists), COX inhibitors(Cyclooxygenases inhibitors) + [4] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date US (22 May 1987), |
Regulation- |
Molecular FormulaC20H23BrN2O4 |
InChIKeySRGKFVAASLQVBO-DASCVMRKSA-N |
CAS Registry2391-03-9 |